Skip to main content
Log in

Neoplasms causing nonhyperinsulinemic hypoglycemia

  • Clinical Research
  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

Non-islet cell tumor hypoglycemia (NICTH) is uncommon. Many of the tumors associated with NICTH are mesenchymal tumors, although carcinomas are also involved in some cases. High serum levels of insulin-like growth factor II (IGF-II) have been associated with NICTH. Analysis of 4 pituitary tumors, 2 adrenocortical tumors, 42 solitary fibrous tumors, and 23 other mesenchymal tumors for IGF-II protein and mRNA showed that most mesenchymal tumors expressed IGF-II protein and mRNA, although only 4 of 48 patients had associated hypoglycemia. Tumor size was related to IGF-II production. Tumors less than 5 cm were usually negative for IGF-II mRNA, whereas 92.3% of tumors greater than 9 cm were positive for IGF-II mRNA.

These results show that IGF-II mRNA and protein can be readily detected in many tumors, even when the tumors are not associated with clinical hypoglycemia. The expression and production of this growth factor cannot accurately predict patients with clinical evidence of hypoglycemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Nadler WH, Wolfer JA. Hepatogenic hypoglycemia associated with primary liver cell carcinoma. Arch Int Med 44:700–705, 1929.

    CAS  Google Scholar 

  2. Doege KW. Fibrosarcoma of the mediastinum. Ann Surg 92:955–960, 1930.

    PubMed  CAS  Google Scholar 

  3. Crawford WH. Hypoglycemia with coma in a case of primary carcinoma of the liver. Am J Med Sci 181:496–502, 1931.

    Article  Google Scholar 

  4. Daughaday WH. The pathophysiology of IGF-II hypersecretion in non-islet cell tumor hypoglycemia. Diabetes Rev 3:62–72, 1995.

    Google Scholar 

  5. Zapf J. Insulin-like growth factor binding proteins and tumor hypoglycemia. Trends Endocrinol Metab 6:37–42, 1995.

    Article  CAS  PubMed  Google Scholar 

  6. Marks V, Teale JD. Tumors producing hypoglycemia. Endocrine Related Cancer 5:111–129, 1998.

    Article  CAS  Google Scholar 

  7. Watson RGP, Johnston CF, O’Hare MMT, Anderson JR, Wilson BG, Collins JSA, Sloan JM, Buchanon KD. The frequency of gastrointestinal endocrine tumors in a well-defined population. Northern Ireland 1970–1985. Quant J Med 72:647–657, 1989.

    CAS  Google Scholar 

  8. Klöppel G, In’t Veld PA, Komminoth P, Heitz PU. The Endocrine Pancreas. In Kovacs K and Asa SL (Eds) Functional Endocrine Pathology. Second Edition Blackwell Science INC. Malder MA 1998 pp 415–487.

    Google Scholar 

  9. Snowden JA, Greaves M, Page K. Reversal of diabetes associated with escape of myeloma: inappropriate IGF-II secretion. Br J Haematol 87:202–204, 1994.

    PubMed  CAS  Google Scholar 

  10. Wasad T, Eguchi Y, Takagara S, Yao K, Hirata Y, Ishii S. Insulin autoimmune syndrome associated with benign monoclonal gammopathy. Evidence for monoclonal insulin autoantibodies. Diabetes Care 12:147–150, 1989.

    Article  Google Scholar 

  11. Walters EG, Tavor JM, Denten RM, Walters G. Hypoglycemia due to an insulin-receptor antibody in Hodgkin’s disease. Lancet 1:241–243, 1987.

    Article  PubMed  CAS  Google Scholar 

  12. Batterlino T, Goto M, Zeller WP. Dexamethasone attenuates hypoglycemia in ten day old rats treated with TNF alpha. Res Comm Mol Pathol Pharmacol 92:149–154, 1996.

    Google Scholar 

  13. Lloyd RV, Jin L, Qian X, Zhang S, Scheithauer BW. Nitric oxide synthase in the human pituitary gland. Am J Pathol 146:86–94, 1995.

    PubMed  CAS  Google Scholar 

  14. Lloyd RV, Jin L. Analysis of chromogranin/secretogranin messenger RNA in human pituitary adenomas. Diagn Mol Pathol 3:38–45, 1994.

    Article  PubMed  CAS  Google Scholar 

  15. Jansen M, van Schaik FM, van Toll H, van den Brande JL, Sussenbach JS. Nucleotide sequences of cDNAs encoding precursors of human insulin-like growth factor II (IGF-II) and an IGF-II variant. FEBS Lett 179:243–246, 1985.

    Article  PubMed  CAS  Google Scholar 

  16. England DM, Hocholzer L, McCarty MJ. Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases. Am J Surg Pathol 13:640–658, 1989.

    Article  PubMed  CAS  Google Scholar 

  17. Strewler GJ. Hormonal manifestations of malignancy. Williams Textbook of Endocrinology. Wilson JD, Foster DW, Kronenberg HM, Larsen PR (Eds). 9th Ed. WB Saunders Co. Philadelphia 1997 pp 1693–1710.

    Google Scholar 

  18. Hoog A, Norquist ACS, Hulting AL, Flakmer UG. High molecular weight IGF-II expression in a haemangiopericytoma associated with hypoglycemia. APMIS 105:469–482, 1997.

    Article  PubMed  CAS  Google Scholar 

  19. Katz LLE, Liu F, Baker B, Agus MSA, Nunn SE, Hintz RL, Cohen P. The effect of growth hormone treatment on the insulin-like growth factor axis in a child with non-islet cell tumor hypoglycemia. J Clin Endocrinol Metab 81:1141–1146, 1996.

    Article  PubMed  CAS  Google Scholar 

  20. Hoff AO, Vassilopoulou-Sellin R. The role of glucagon administration in the diagnosis and treatment of patients with tumor hypoglycemia. Cancer 82:1585–1592, 1998.

    Article  PubMed  CAS  Google Scholar 

  21. Bommer G, Altenähr E, Kühnan J Jr, Klöppel G. Ultrastruture of hemangiopericytoma associated with paraneoplastic hypoglycemia. Z Krebsforsch 85:231–241, 1976.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ricardo V. Lloyd MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lloyd, R.V., Erickson, L.A., Nascimento, A.G. et al. Neoplasms causing nonhyperinsulinemic hypoglycemia. Endocr Pathol 10, 291–297 (1999). https://doi.org/10.1007/BF02739771

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02739771

Key Words

Navigation